- Home
- SGMO vs ORMP Comparison
SGMO vs ORMP Comparison
Compare SGMO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGMO | ORMP |
|---|---|---|
| Founded | 1995 | 2002 |
| Country | United States | United States |
| Employees | 183 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.1M | 117.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMO | ORMP |
|---|---|---|
| Price | $0.41 | $3.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.60 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 273.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $32,875,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $1.82 |
| 52 Week High | $1.40 | $3.71 |
Technical Indicators
Market Signals| Indicator | SGMO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 75.70 |
| Support Level | $0.43 | $3.32 |
| Resistance Level | $0.48 | $3.54 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 8.32 | 97.91 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.